This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Oncology
Adagrasib approved in the UK for NSCLC after earlier EU rejection
Read more
Novel injectable bispecific antibody for advanced lymphoma receives EU and UK green light
Read more
Positive CHMP opinion for rucaparib in advanced ovarian cancer
Read more
Bispecific antibody glofitamab available on the NHS ‘within weeks‘ for advanced lymphoma
Read more
EADV: Improvement in AI skin cancer detection as software identifies all melanoma cases
Read more
EADV: New analysis shows non-melanoma skin cancer has higher mortality rate than melanoma
Read more
CRUK analysis reveals two million years of life lost to cancer annually but highlights progress
Read more
Circulating tumour DNA biopsy helps identify NSCLC patients suitable for radiotherapy
Read more
Stereotactic radiotherapy equivalent to standard care in localised prostate cancer, study finds
Read more
Could enhancing the gut microbiome impede disease progression in melanoma?
Read more
Does cancer screening actually reduce all-cause mortality?
Read more
Ruxolitinib approved by NICE for treatment of polycythaemia vera
Read more
Pilot project set to improve ethnic diversity in breast cancer clinical trials
Read more
Two genes found to confer multidrug chemoresistance in head and neck cancers
Read more
Alectinib shows promise in early-stage ALK-positive non-small cell lung cancer
Read more
Specific enzyme tissue expression close to tumour may predict survival in NSCLC
Read more
SC atezolizumab set for NHS rollout, offering faster and more convenient cancer treatment
Read more
Page 3 of 40
«
1
2
3
4
5
...
10
20
30
...
»
Last »
Popular articles
New protocol for IBD referral triage reduces diagnostic delays, say researchers
24 April, 2024
Bimekizumab gains EC approval for hidradenitis suppurativa
22 April, 2024
Semaglutide shows promise in patients with type 2 diabetes and obesity-related heart failure
22 April, 2024
x
Search for: